Differential roles of prostaglandin E-type receptors in activation of hypoxia-inducible factor 1 by prostaglandin E1 in vascular-derived cells under non-hypoxic conditions

Kengo Suzuki, Kenichiro Nishi, Satoshi Takabuchi, Shinichi Kai, Tomonori Matsuyama, Shin Kurosawa, Takehiko Adachi, Takayuki Maruyama, Kazuhiko Fukuda, Kiichi Hirota

    Research output: Contribution to journalArticle

    7 Citations (Scopus)

    Abstract

    Prostaglandin E1 (PGE1), known pharmaceutically as alprostadil, has vasodilatory properties and is used widely in various clinical settings. In addition to acute vasodilatory properties, PGE1 may exert beneficial effects by altering protein expression of vascular cells. PGE1 is reported to be a potent stimulator of angiogenesis via upregulation of VEGF expression, which is under the control of the transcription factor hypoxia-inducible factor 1 (HIF-1). However, the molecular mechanisms behind the phenomenon are largely unknown. In the present study, we investigated the mechanism by which PGE1 induces HIF-1 activation and VEGF gene expression in human aortic smooth muscle cells (HASMCs) and human umbilical vein endothelial cells (HUVECs), both vascular-derived cells. HUVECs and HASMCs were treated with PGE1 at clinically relevant concentrations under 20% O2 conditions and HIF-1 protein expression was investigated. Expression of HIF-1α protein and the HIF-1-downstream genes were low under 20% O2 conditions and increased in response to PGE1 treatment in both HUVECs and HASMCs in a dose- and timedependent manner under 20% O2 conditions as comparable to exposure to 1% O2 conditions. Studies using EP-receptor-specific agonists and antagonists revealed that EP1 and EP3 are critical to PGE1-induced HIF-1 activation. In vitro vascular permeability assays using HUVECs indicated that PGE1 increased vascular permeability in HUVECs. Thus, we demonstrate that PGE1 induces HIF-1α protein expression and HIF-1 activation under non-hypoxic conditions and also provide evidence that the activity of multiple signal transduction pathways downstream of EP1 and EP3 receptors is required for HIF-1 activation.

    Original languageEnglish
    Article number220
    JournalPeerJ
    Volume2013
    Issue number1
    DOIs
    Publication statusPublished - 2013

    Keywords

    • Angiogenesis
    • EP receptor
    • Human endothelial cells
    • Human smooth muscle cells
    • Hypoxia-inducible factor
    • Prostaglandin E1
    • VEGF

    ASJC Scopus subject areas

    • Neuroscience(all)
    • Biochemistry, Genetics and Molecular Biology(all)
    • Agricultural and Biological Sciences(all)

    Fingerprint Dive into the research topics of 'Differential roles of prostaglandin E-type receptors in activation of hypoxia-inducible factor 1 by prostaglandin E<sub>1</sub> in vascular-derived cells under non-hypoxic conditions'. Together they form a unique fingerprint.

  • Cite this

    Suzuki, K., Nishi, K., Takabuchi, S., Kai, S., Matsuyama, T., Kurosawa, S., Adachi, T., Maruyama, T., Fukuda, K., & Hirota, K. (2013). Differential roles of prostaglandin E-type receptors in activation of hypoxia-inducible factor 1 by prostaglandin E1 in vascular-derived cells under non-hypoxic conditions. PeerJ, 2013(1), [220]. https://doi.org/10.7717/peerj.220